Elucidating the precise pharmacological mechanism of action (MOA) of naturally occurring compounds is often difficult. Whilst Tarselli et al. (60) designed the first de novo artificial pathway to conolidine and showcased that this naturally happening compound effectively suppresses responses to the two chemically induced and inflammation-derived pain, the pharmacologic https://carsony754byh0.corpfinwiki.com/user